The nonprofit Children’s Health Defense sued the US Food and Drug Administration for withholding the results of key COVID-19 vaccine safety analyses.
Since the start of the COVID pandemic, the FDA has acted like a proxy for Big Pharma and blocked effective treatments for the virus while at the same time approving dangerous and ineffective COVID vaccines.
The FDA lied about Ivermectin and later lied that they lied about Ivermectin.
The FDA also ignored the thousands of deaths and tens of thousands of reported hospitalizations linked to the experimental COVID vaccines.
The FDA did not protect the US public. The FDA was a rubber stamp for Big Pharma.
How many Americans died and continue to die due to their negligence?
The Epoch Times reported:
The U.S. Food and Drug Administration (FDA) has been sued for withholding the results of key COVID-19 vaccine safety analyses.
The FDA’s actions violate federal law, the new lawsuit, filed on Jan. 26 in federal court in Washington by the nonprofit Children’s Health Defense (CHD), alleges.
The suit is seeking the raw results from the FDA’s analyses of reports to the Vaccine Adverse Event Reporting System (VAERS).
The system, which the FDA runs with the U.S. Centers for Disease Control and Prevention, accepts reports of post-vaccination adverse events.
As part of its vaccine safety monitoring, the FDA pledged to run a type of analyses called Empirical Bayesian (EB) data mining on the reports to see if any safety signals were triggered. Signals give agencies an idea of which problems may be caused by vaccines. Agencies are supposed to research signals to verify them or rule them unrelated to vaccination.
“A report to VAERS does not mean that a vaccine caused an adverse event. But VAERS can give CDC and FDA important information. If it looks as though a vaccine might be causing a problem, FDA and CDC will investigate further and take action if needed,” the CDC says on its website.
The FDA denied CHD’s request for the results of the data mining, claiming the records are “intra-agency memoranda consisting of opinions, recommendations, and policy discussions within the deliberative process of FDA, from which factual information is not reasonably segregable.”